1. Home
  2. ATYR vs NREF Comparison

ATYR vs NREF Comparison

Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • NREF
  • Stock Information
  • Founded
  • ATYR 2005
  • NREF 2019
  • Country
  • ATYR United States
  • NREF United States
  • Employees
  • ATYR N/A
  • NREF N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • NREF Real Estate Investment Trusts
  • Sector
  • ATYR Health Care
  • NREF Real Estate
  • Exchange
  • ATYR Nasdaq
  • NREF Nasdaq
  • Market Cap
  • ATYR 535.0M
  • NREF 264.1M
  • IPO Year
  • ATYR 2015
  • NREF 2020
  • Fundamental
  • Price
  • ATYR $6.03
  • NREF $15.35
  • Analyst Decision
  • ATYR Strong Buy
  • NREF Hold
  • Analyst Count
  • ATYR 5
  • NREF 4
  • Target Price
  • ATYR $23.25
  • NREF $14.75
  • AVG Volume (30 Days)
  • ATYR 4.9M
  • NREF 40.6K
  • Earning Date
  • ATYR 11-06-2025
  • NREF 10-30-2025
  • Dividend Yield
  • ATYR N/A
  • NREF 13.05%
  • EPS Growth
  • ATYR N/A
  • NREF N/A
  • EPS
  • ATYR N/A
  • NREF 2.59
  • Revenue
  • ATYR N/A
  • NREF $121,573,000.00
  • Revenue This Year
  • ATYR $478.72
  • NREF $27.27
  • Revenue Next Year
  • ATYR $1,899.26
  • NREF $5.40
  • P/E Ratio
  • ATYR N/A
  • NREF $5.92
  • Revenue Growth
  • ATYR N/A
  • NREF 302.49
  • 52 Week Low
  • ATYR $1.67
  • NREF $12.14
  • 52 Week High
  • ATYR $7.29
  • NREF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 62.69
  • NREF 59.68
  • Support Level
  • ATYR $5.08
  • NREF $15.04
  • Resistance Level
  • ATYR $5.77
  • NREF $15.60
  • Average True Range (ATR)
  • ATYR 0.47
  • NREF 0.32
  • MACD
  • ATYR 0.04
  • NREF -0.00
  • Stochastic Oscillator
  • ATYR 68.03
  • NREF 70.24

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: